Temitayo A. Ogunleye, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology University City
View 1 additional location
Schedule onlineCall 215-662-8060
Penn Medicine Provider

About me

  • Professor of Clinical Dermatology

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Albert Einstein Medical Center
  • Residency: University of Michigan Health

Spoken languages

English
English

Reviews

Average Rating

1610 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
she's the best!
Anonymous
May 2026
worth the time and money
Anonymous
May 2026
she's a great doctor
Anonymous
May 2026
dr o is the best dermatologist that i've ever had, and i trust her completely

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ogunleye is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

Research

Publications

Alomary SA, Baker NJ, Schell N, Ogunleye T, Taylor S, Milbar H An Analysis of TSH Levels in Patients with Nonscarring Alopecia: A Single-Center Retrospective Comparative Study , The Journal of Clinical and Aesthetic Dermatology : 2026

Alomary SA, Baker NJ, Ogunleye T, Taylor ST Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System , JAAD Int, 25: 2026,92-94

Baker NJ, Alomary SA, Ogunleye T, Taylor S Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study , J Cutan Med Surg: 2026

Baker NJ, Alomary SA, Ogunleye T, Taylor S Risk of Psychiatric Comorbidities in Non-Scarring Versus Scarring Alopecia: A Retrospective Cohort Study , J Cutan Med Surg: 2026

Jackson S, Sidhu K, Durango KP, Hislop C, Obeng-Nyarko CN, Milbar H, Ogunleye TA, Taylor SC Patient Perspectives and Attitudes Toward the Diagnostic Process for Central Centrifugal Cicatricial Alopecia , J Drugs Dermatol, 25(3): 2026,282-85

Alomary SA, Baker NJ, Ogunleye T, Taylor SC Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System , JAAD Int, 25: 2026,92-94

Encarnacion IN, Desir N, Schell N, Mehta A, Ogunleye T, Taylor S Visit Complexity Differs Between Scarring and Nonscarring Alopecia: A Five-Year DataDerm Analysis , J Am Acad Dermatol, S0190-9622(26): 2026

Encarnacion IN, Desir N, Anusionwu ID, Hislop C, Feldman E, Ogunleye T, Taylor S GLP-1 Receptor Agonists in Overweight and Obese Patients with Hidradenitis Suppurativa , J Drugs Dermatol, 25(2): 2026,178-80

Ogunleye TA Patient Perspectives on Scalp Biopsies for CCCA , Journal of Drugs in Dermatology Buzz Series: 2026

Desir N, Encarnacion I, Oyasiji O, Durango K, Obeng-Nyarko C, Ogunleye, Taylor S Intralesional corticosteroid injection technique for scarring and nonscarring alopecia: A cross-sectional survey of hair experts in the United States , JAAD: 2025